Guidelines: Safe-by-design for medicinal polymeric nanocarriers

A novel guideline document elaborated by the EU-consortium GoNanoBioMat and presented at the final dissemination event. The GoNanoBioMat framework is designed to elaborate current knowledge to small and medium-sized enterprises (SMEs), their suppliers, service providers and research institutes at the interface of nanomaterials and nanomedicine. The  Swiss partners in the consortium were funded by Innosuisse.

Related articles

Clinam Summit in Basel This year, the 14th European and Global Summit for Clinical Nanomedicine (CLINAM Summit) organized by the European Foundation for Clinical Nanomedicine will take place on 8-11 October
The MACRAMÉ Project, a 36-months research and innovation action, funded by the European Commission’s Horizon Europe Framework Programme, commenced its ambitious, collaborative workprogramme on the characterisation and
Publications on Synthetic... Action plan Synthetic Nanomaterials Final report 2 September 2020 (only available in German and French) Opportunities and Risks of Nanomaterials Journal of Nanobiotechnology, 2017 Opportunities and Risks
Country-scale calculation... Plastic particles less than five millimeters in size, also known as microplastics, often settle far away from their point of origin. Empa researchers have now developed a
Need help with the regist... eREACHNano is a new free web tool focused on helping small and medium-sized companies that may lack sufficient in-house expertise on the regulation covering nanomaterials.
The need for awareness an... Published in Nature Nanotechnology by the group of Alke Petri-Fink and Barbara Rothen-Rutishauer (www.nature.com/articles/s41565-023-01331-4). The authors discuss the safety concerns on handling and disposing nanomaterials, the possible
Microplastics and Nanopla... Recently, the European Commission published a study that provides further information on the intentional uses of microplastic particles in products and the risks they pose to human
Crucial results for coron... Empa researcher Peter Wick, Head of the Particles-Biology Interactions Laboratory in St. Gallen and Director of contactpointnano.ch talks to Empa Quarterly about recent antibody studies, which are
Nanomedicine: The Minuten... Tiny particles that can fight cancer or that can easily pass through any interface within our body are a great promise for medicine. But there is little
Characterizing Nanopartic... Live Webinar, Thursday 19 November, 15:00 (Zürich). Guest speaker Dr. Sandor Balog, Details, Please register for this event using this link